Matrosovich, M. N., Matrosovich, T. Y., Gray, T., Roberts, N. A. & Klenk, H.-D. Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J. Virol. 78, 12665–12667 (2004).
Google Scholar
Palese, P., Tobita, K., Ueda, M. & Compans, R. W. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61, 397–410 (1974).
Google Scholar
de Vries, E., Du, W., Guo, H. & de Haan, C. A. M. Influenza A virus hemagglutinin-neuraminidase-receptor balance: preserving virus motility. Trends Microbiol. 28, 57–67 (2020).
Google Scholar
Couch, R. B. et al. Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase. J. Infect. Dis. 207, 974–981 (2013).
Google Scholar
Monto, A. S. et al. Antibody to influenza virus neuraminidase: an independent correlate of protection. J. Infect. Dis. 212, 1191–1199 (2015).
Google Scholar
Ng, S. et al. Novel correlates of protection against pandemic H1N1 influenza A virus infection. Nat. Med. 25, 962–967 (2019).
Google Scholar
Maier, H. E. et al. Pre-existing antineuraminidase antibodies are associated with shortened duration of influenza A(H1N1)pdm virus shedding and illness in naturally infected adults. Clin. Infect. Dis. 70, 2290–2297 (2020).
Google Scholar
Weiss, C. D. et al. Neutralizing and neuraminidase antibodies correlate with protection against influenza during a late season A/H3N2 outbreak among unvaccinated military recruits. Clin. Infect. Dis. 71, 3096–3102 (2020).
Google Scholar
Black, S. et al. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza Vaccines in children. Pediatr. Infect. Dis. J. 30, 1081–1085 (2011).
Google Scholar
Chen, Y. Q. et al. Influenza infection in humans induces broadly cross-reactive and protective neuraminidase-reactive antibodies. Cell 173, 417–429.e10 (2018).
Google Scholar
Laguio-Vila, M. R. et al. Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010-2011 trivalent inactivated influenza vaccination in healthcare personnel. Open Forum Infect. Dis. 2, ofu115 (2015).
Google Scholar
Air, G. M. Influenza neuraminidase. Influenza Other Resp. Viruses 6, 245–256 (2012).
Google Scholar
Yasuhara, A. et al. Antigenic drift originating from changes to the lateral surface of the neuraminidase head of influenza A virus. Nat. Microbiol. 4, 1024–1034 (2019).
Google Scholar
Johansson, B. E., Matthews, J. T. & Kilbourne, E. D. Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response. Vaccine 16, 1009–1015 (1998).
Google Scholar
Sultana, I. et al. Stability of neuraminidase in inactivated influenza vaccines. Vaccine 32, 2225–2230 (2014).
Google Scholar
Deroo, T., Min Jou, W. & Fiers, W. Recombinant neuraminidase vaccine protects against lethal influenza. Vaccine 14, 561–569 (1996).
Google Scholar
McMahon, M. et al. Correctly folded – but not necessarily functional – influenza virus neuraminidase is required to induce protective antibody responses in mice. Vaccine 38, 7129–7137 (2020).
Google Scholar
von Grafenstein, S. et al. Interface dynamics explain assembly dependency of influenza neuraminidase catalytic activity. J. Biomol. Struct. Dyn. 33, 104–120 (2015).
Google Scholar
da Silva, D. V., Nordholm, J., Madjo, U., Pfeiffer, A. & Daniels, R. Assembly of subtype 1 influenza neuraminidase is driven by both the transmembrane and head domains. J. Biol. Chem. 288, 644–653 (2013).
Google Scholar
Dai, M. et al. Identification of residues that affect oligomerization and/or enzymatic activity of influenza virus H5N1 neuraminidase proteins. J. Virol. 90, 9457–9470 (2016).
Google Scholar
de Filette, M., Deroo, T. M., Fiers, W., Maras, M. & Min Jou, W. A. Oligomeric complexes of chimeric proteins with enhanced immunogenic potential. International application published under the patent cooperation treaty WO 02/074795 A2 (2002).
Schmidt, P. M., Attwood, R. M., Mohr, P. G., Barrett, S. A. & McKimm-Breschkin, J. L. A generic system for the expression and purification of soluble and stable influenza neuraminidase. PLoS ONE 6, e16284 (2011).
Google Scholar
Stetefeld, J. et al. Crystal structure of a naturally occurring parallel right-handed coiled coil tetramer. Nat. Struct. Biol. 7, 772–776 (2000).
Google Scholar
Gao, J. et al. Design of the recombinant influenza neuraminidase antigen is crucial for its biochemical properties and protective efficacy. J. Virol. 95, e0116021 (2021).
Google Scholar
Job, E. R. et al. Broadened immunity against influenza by vaccination with computationally designed influenza virus N1 neuraminidase constructs. npj Vaccines 3, 55 (2018).
Google Scholar
Streltsov, V. A., Schmidt, P. M. & McKimm-Breschkin, J. L. Structure of an Influenza A virus N9 neuraminidase with a tetrabrachion-domain stalk. Acta Crystallogr. Sect. F. Struct. Biol. Commun. 75, 89–97 (2019).
Google Scholar
Wernersson, S. et al. IgG-mediated enhancement of antibody responses is low in Fc receptor gamma chain-deficient mice and increased in Fc gamma RII-deficient mice. J. Immunol. 163, 618–622 (1999).
Google Scholar
Nimmerjahn, F. & Ravetch, J. V. Fcγ receptors as regulators of immune responses. Nat. Rev. Immunol. 8, 34–47 (2008).
Google Scholar
Heyman, B. Regulation of antibody responses via antibodies, complement, and Fc receptors. Annu. Rev. Immunol. 18, 709–737 (2000).
Google Scholar
Verstrepen, B. E. et al. Vaccine-induced protection of rhesus macaques against plasma viremia after intradermal infection with a European lineage 1 strain of West Nile virus. PLoS ONE 9, e112568 (2014).
Google Scholar
Zarnitsyna, V. I. et al. Masking of antigenic epitopes by antibodies shapes the humoral immune response to influenza. Philos. Trans. R. Soc. B Biol. Sci. 370, 20140248. https://doi.org/10.1098/rstb.2014.0248 (2015).
Google Scholar
Zarnitsyna, V. I., Lavine, J., Ellebedy, A., Ahmed, R. & Antia, R. Multi-epitope models explain how pre-existing antibodies affect the generation of broadly protective responses to influenza. PLoS Pathog. 12, e1005692 (2016).
Google Scholar
Heesters, B. A. et al. Endocytosis and recycling of immune complexes by follicular dendritic cells enhances B cell antigen binding and activation. Immunity 38, 1164–1175 (2013).
Google Scholar
Baker, K., Rath, T., Pyzik, M. & Blumberg, R. S. The role of FcRn in antigen presentation. Front. Immunol. https://doi.org/10.3389/fimmu.2014.00408 (2014).
de Ståhl, T. D., Dahlström, J., Carroll, M. C. & Heyman, B. A role for complement in feedback enhancement of antibody responses by IgG3. J. Exp. Med. 197, 1183–1190 (2003).
Google Scholar
Kranich, J. & Krautler, N. J. How follicular dendritic cells shape the B-cell antigenome. Front. Immunol. 7, 225 (2016).
Google Scholar
Zhang, L., Ding, Z. & Heyman, B. IgG3-antigen complexes are deposited on follicular dendritic cells in the presence of C1q and C3. Sci. Rep. https://doi.org/10.1038/s41598-017-05704-3 (2017).
Job, E. R. et al. Broadened immunity against influenza by vaccination with computationally designed influenza virus N1 neuraminidase constructs. npj Vaccines 3, 55 (2018).
Google Scholar
Rossey, I. et al. Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state. Nat. Commun. 8, 16165 (2017).
Caillet, C. et al. AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice. Vaccine 28, 3076–3079 (2010).
Google Scholar
